The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Animal testing for new drugs is being phased out because of advances made in artificial intelligence (AI), the UK’s medicines regulator has said. In an announcement on Tuesday, the Medicines and ...

Many U.S. hospitals using predictive models are not evaluating their tools internally for accuracy, and fewer still are evaluating them for potential biases, according to a study published in the most ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

The US Food and Drug Administration (FDA) has announced plans to begin replacing animal testing in drug development with “more effective, human-relevant methods”, including AI models and lab-based ...

For businesses seeking to deploy AI models in their operations — either for employees or customers to use — one of the most critical questions isn't even what model or what to use it for, but when ...

Torie Bosch is the First Opinion editor at STAT. First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...

Openlayer Inc., the creator of a novel platform for testing artificial intelligence and machine learning models, said today it has closed on a $4.8 million seed funding round. The round was led by ...

Nio has started testing the first model from its new entry-level Alps brand in China ahead of an expected launch in around October. In news that won’t surprise anyone, Alps’ first model is expected to ...